NCT03766347View on ClinicalTrials.gov

Pediatric NMOSD Observational Study

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2018

Primary Completion Date

April 3, 2024

Study Completion Date

April 3, 2024

Conditions
Neuromyelitis OpticaNMO Spectrum Disorder
Trial Locations (1)

55905

Mayo Clinic, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

Alexion Pharmaceuticals, Inc.

INDUSTRY

lead

Mayo Clinic

OTHER

NCT03766347 - Pediatric NMOSD Observational Study | Biotech Hunter | Biotech Hunter